MediWound
MDWD
24 hedge funds and large institutions have $26.4M invested in MediWound in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
2.03% less ownership
Funds ownership: 30.77% → 28.74% (-2%)
8% less funds holding
Funds holding: 26 → 24 (-2)
37% less capital invested
Capital invested by funds: $41.8M → $26.4M (-$15.4M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$424K |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$68.3K |
| 3 |
BF
BOK Financial
Tulsa,
Oklahoma
|
+$52.6K |
| 4 |
OC
Oppenheimer & Co
New York
|
+$48.5K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$44.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$1.38M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$619K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$322K |
| 4 |
JP Morgan Chase
New York
|
-$224K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$193K |
MDWD Hedge Fund Activity: Q2 2019 in Review
24 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q2 2019, worth a combined $26.4M — down 37% from $41.8M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MDWD and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was ARK Investment Management, opening a new position worth an estimated $424K. The largest seller was Meitav Investment House, cutting an estimated $1.38M.
- 24 institutional investors held MediWound (MDWD) as of Q2 2019, down from 26 in Q1 2019.
- Funds reported $26.4M of MediWound stock for Q2 2019, down 37% quarter-over-quarter.
- 3 funds opened new MediWound positions in Q2 2019 and 5 closed out, a net change of -2 holders.
- The largest MediWound buyer in Q2 2019 was ARK Investment Management, an estimated $424K added.
- The largest MediWound seller in Q2 2019 was Meitav Investment House, an estimated $1.38M sold.
Based on aggregated 13F filings for Q2 2019.